Universal strategy to generate lentiviral vectors encoding lethal proteins.

Area of Science:

• Gene Therapy
• Molecular Biology
• Virology

Background:

• Lentiviral vectors are a promising gene therapy tool.
• Packaging lethal transgenes into lentiviral vectors is challenging due to toxicity in producer cells.

Purpose of the Study:

• To develop a novel multi-layered approach for packaging and delivering toxic genes using lentiviral vectors.
• To overcome challenges associated with lentiviral vector production encoding lethal transgenes.

Main Methods:

• Utilized a combination of a regulatable promoter, inverted transgene orientation, and CRISPR-based inhibition.
• Developed a system to repress vector transgene transcription in producer cells.

Main Results:

• Successfully reduced toxicity in producer cells, enabling high-titer lentiviral vector production.
• Demonstrated efficient delivery of transgenes encoding pro-apoptotic proteins and toxins to cancer cells.
• Achieved targeted cell death in cancer cells, validating therapeutic payload delivery.

Conclusions:

• Established an innovative framework to expand lentiviral vector utility for controlled delivery of cytotoxic factors.
• This approach provides a proof of concept for gene therapy applications involving toxic payloads.
• The developed method enhances the safety and efficacy of lentiviral vectors for therapeutic gene delivery.